Physician profile
Kyle Marten Altman
NPI 1659805596
$14,111.60
in general payments reported to CMS, 2019-2025
17 companies · $1,464 in 2025
The $1,464 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,996 · 2021: $4,031 · 2022: $4,488 · 2023: $1,473 · 2024: $659 · 2025: $1,464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,692 · Travel and Lodging: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,691.54 |
| Travel and Lodging | $904.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $9,187.07 | 2019-2022 | |
| Stryker Corporation | $2,358.65 | 2021-2025 | Mako, Blueprint Patient Specific Instrumentation, Triathlon |
| Arthrex, INC. | $795.55 | 2024-2025 | Arthrex |
| Zimmer Biomet Holdings, INC. | $536.18 | 2023-2024 | |
| Mission Medical Distribution, LLC | $469.61 | 2025 | |
| Smith+Nephew, INC. | $178.92 | 2022-2023 | Pico, Pico 7, Renasys Touch |
| Depuy Synthes Sales INC. | $144.76 | 2023 | |
| Melinta Therapeutics, LLC | $129.52 | 2022-2023 | Orbactiv, Kimyrsa |
| Acumed LLC | $104.98 | 2024 | Acumed |
| Ferring Pharmaceuticals INC. | $72.92 | 2022-2023 | Euflexxa |
| Abbvie INC. | $37.09 | 2023 | Dalvance |
| Kowa Pharmaceuticals America, INC. | $25.76 | 2023 | Seglentis |
| Novo Nordisk INC | $16.86 | 2023 | Wegovy |
| Bioventus LLC | $16.85 | 2023 | Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $14.68 | 2023 | Zilretta, Iovera, Exparel |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $12.84 | 2022 | |
| Ethicon US, LLC | $9.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Altman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.